Pembrolizumab-Related Neuroinflammation: A Case Report and Review of the Literature
We report, to our knowledge, the first case of extralimbic pembrolizumab‐related neuroinflammation in a 71-year-old man with insidious and progressive neurologic decline during single-agent therapy for metastatic melanoma. The imaging features are nonspecific and consistent with
a progressive leukoencephalopathy, for which paraneoplastic, autoimmune, and infectious encephalitis are diagnostic considerations. Recognition of this entity is important because checkpoint inhibitor treatments are increasing and permanent neurologic sequelae may be thwarted with the cessation
of therapy and implementation of immunosuppression.
Keywords: CTLA = cytotoxic T-lymphocyte-associated protein; PD-1 = programmed cell death protein 1; PD-L1 = programmed death-ligand 1
Document Type: Research Article
Publication date: April 1, 2018
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content